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Membranous glomerulonephritis: Long-term serial observations
on clinical course and morphology. The natural history of diffuse
membranous glomerulonephritis in 32 patients followed for five
years or more, or until death, remission or the development of
uremia is presented. The disease was diagnosed by light or
electron microscopy employing rigid criteria, principally the
appearance of subepithelial or intramembranous deposits in the
peripheral capillary loops of all unhyalinized glomeruli. Ten
patients developed uremia an average of 2.7 years after the
clinical onset. Uremia appeared in four other patients but more
slowly, i.e., 6, 8, 9, and 19 years after the onset. Two patients
have died without uremia. Nine patients exhibited slow progres-
sion of the disease with persistent heavy proteinuria and moder-
ately depressed function and have lived for as long as 23 years
after proteinuria was first detected. Seven patients have entered
remission, five with the complete disappearance of proteinuria.
Subepithelial deposits were dense and electron opaque early in
the course of the disease and in patients who followed a rapid
clinical course to uremia. By light microscopy, the basement
membrane appeared to thicken with time in those in whom the
disease progressed, including those in whom progression was
slow. Deposits were more likely to be intramembranous and
lucent in older lesions and appeared to disappear in patients who
entered remission.
Glomérulonéphrite membraneuse: Evolution clinigue et morpho-
logie au cours d'une étude répétitive a long terme. L'histoire
naturelle de Ia glomérulonéphrite membraneuse diffuse chez
32 malades suivis pendant 5 ans ou plus, ou jusqu'au decès, a Ia
remission ou a l'installation de t'urémie est présentée. Le
diagnostic a été établi par Ia microscopie optique ou électronique
en fonction de critéres rigides, principalement l'existence de
dépôts sous épithéliaux ou intramembraneux dans les anses
capillaires péripheriques de tous les glomérules non hyalinisés.
Dix malades ont développé une insuffisance rénale en 2,7 ans,
en moyenne, aprés le debut clinique. Deux malades sont morts
sans insuffisance rénale. Neuf malades ont eu une evolution lente
de Ia maladie, avec une protéinurie importante et une di-
minution moderee de Ia fonction rénale, et ont vécu jusqu'à 23
ans après Ia premiere constatation de Ia protéinurie. Sept malades
sont entrés en remission, cinq d'entre eux avec disparition de Ia
protéinurie. Les dépôts sous épithéliaux étaient denses et opaques
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aux electrons tot dans l'évolution de Ia maladie et chez les
malades dont l'évolution vers l'insuffisance rénale était rapide.
En microscopie optique, les membranes basales paraissaient
s'épaissir avec le temps chez les malades dont l'affection pro-
gressait, mCme chez ceux dont Ia progression était lente. Les
dépôts étaient plus frequemment intramembraneux et clairs dans
les lesions anciennes et disparaissaient chez les malades en
remission.
Few reports have dealt with the natural history and prog-
nosis of membranous glomerular changes in patients fol-
lowed for long periods of time. From early in 1942 when
Ellis [1] reported a high mortality in his type II nephritis,
it was supposed that the prognosis in membranous gb-
merulonephritis was uniformly poor, but until recently
there were few survival statistics on patients with mem-
branous glomerulonephritis documented by renal biopsy.
In 1968 Pollak, Rosen and Pirani [2] reported on a group
of patients, 21 of whom had membranous gbomerubo-
nephritis. One patient died of renal failure six years after
the onset of symptoms. Slow deterioration of renal function
occurred in some patients but in others there was no
deterioration of function over an average period of five
years. Complete clinical recovery occurred in four patients.
The severity of glomerular lesions increased slowly or re-
mained static for periods ranging from months to years.
Habib and Kleinknecht [3] have also reported a significant
incidence of remission in children, but the experience of
Forland and Spargo [4] with a group of 19 patients with
membranous glomerular change was less satisfactory. Nine
of these patients died, with a mean survival of six years
after clinical onset, and six of these nine patients died in
renal failure. Ehrenreich and Churg [5] also have reported
a significant incidence of death in renal failure in patients
with membranous glomerulonephritis and the nephrotic
syndrome; of 60 adults and children, 14 died in renal
failure.
The present paper describes the natural history of diffuse
membranous gbomerubonephritis in a group of 32 patients
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who presented with marked proteinuria, often with the
nephrotic syndrome, and whose glomerular lesions were
classified by rigid histologic and electron microscopic
criteria. Each patient had been followed carefully in the
same center with standard laboratory procedures for at
least five years or until the onset of uremia, death or
remission.
Methods
Tissue. Renal tissue was obtained from percutaneous
renal biopsies using a Vim Silverman needle according to
techniques previously described [6]. Some specimens were
obtained at autopsy and one at nephrectomy.
Light and electron microscopic techniques. Each biopsy
specimen, immediately after its removal from the patient,
was cut into two pieces under a dissecting microscope. One
piece was fixed for three hours in Helly's fluid, then em-
bedded in paraffin and serially sectioned for examination
by light microscopy. Sections cut at 2 ii and 6 jt from these
blocks were stained with hematoxylin and eosin, the
periodic acid-Schiff (PAS) method with a hematoxylin
counterstain, and Heidenhain's modification of Mallory's
connective tissue stain [6]. In selected cases, PAS-methan-
amine silver stains also were performed [7].
The second piece of tissue was cut under cold, phosphate-
buffered osmium tetroxide [8] into approximately 1 mm
cubes which were fixed at 4° C for one to two hours. These
cubes were then dehydrated at room temperature through
graded alcohols and since 1962 have been embedded in
Epon 812, after the manner of Luft [9]. Prior to 1960, the
tissue was embedded in methacryalate. Vestapol-W [10]
was used between 1960 and 1962. Sections were cut on a
Porter-Blum MT-i ultramicrotome, using glass or diamond
knives. Some sections 0.5 ji thick were mounted on glass
microscope slides, stained with toluidine blue [ii] and
examined by light microscopy. Ultrathin sections were
mounted on copper grids, stained with lead citrate and/or
uranyl acetate and examined with an electron microscope
(Philips EM-200 or RCA EMU-3 C).
Since 1964, a third piece of tissue has been taken for
immunofluorescence study. However, these techniques were
applied to too few patients who qualified for the present
study to warrant presentation.
When the initial tissue did not contain glomeruli, tissue in
some paraffin blocks was excised, placed in melted paraffin,
deparaffinized with several changes of xylol and rehydrated
in a series of alcohols. It was then cut into tiny cubes, fixed
in 1 % osmium tetroxide as above and embedded in epon.
Sections prepared by this technique were adequate to
detect glomerular subepithelial deposits.
Definition of diffuse membranous glomerulonephritis. The
renal disease manifested by the patients was classified as
membranous glomerulonephritis if the biopsy exhibited
the following changes:
1. Light microscopy: All unhyalinized glomeruli were
diseased and showed thickening of the walls of all peripheral
capillary loops. A thin subepithelial red line on sections
stained with Heidenhain's-Mallory connective tissue stain
can be demonstrated in most sections with mild to moderate
thickening of glomerular basement membrane. Such a "red
line" was seen in one or more biopsy specimens of all but
thirteen of the patients in the series, but it was not detectable
when total capillary wall thickening was very marked or
when the deposit was very thin, or when proteinuria had
disappeared.
Patients with focal thickening, as well as those with
thickening of the capillary wall by light microscopy asso-
ciated with obvious intracapillary cell proliferation (mixed
membranous and proliferative glomerulonephritis) were
excluded from this study. Also excluded were four patients
with systemic lupus erythematosus who exhibited diffuse
membranous lesions by light and electron microscopy.
2. Electron microscopy: Deposits of variable density were
found in a subepithelial position on or within the basement
membrane of the peripheral capillary loops of all un-
hyalinized glomeruli. All patients with slight or no thicken-
ing of the basement membrane of the peripheral capillary
loops by light microscopy were included in the series only
if electron microscopy revealed characteristic subepithelial
or intramembranous deposits.
Capillary wall thickening was quantitated according to
the scheme used by Pollak, Rosen and Pirani [2], in which 0
indicates no thickening, indicates questionable thicken-
ing, 1 + indicates mild thickening, 2+ indicates moderate
thickening without narrowing of capillary lumina, 3 + in-
dicates moderately severe thickening with moderate nar-
rowing of capillary lumina, and 4+ indicates severe thicken-
ing with marked narrowing or obliteration of capillary
lumina. Other histologic parameters were also evaluated
semiquantitatively on a scale ranging from 0 (no change) to
4+ (severe change). Glomerular hyalinization, inflamma-
tion, proliferation (epithelial or endothelial), necrosis,
thrombosis or hyaline droplet change was noted when
present as were tubular atrophy, fatty change, and hyaline
droplet changes. The state of the interstitial tissue and blood
vessels was also noted. Electron micrographs were examined
specifically for alterations in the lamina densa, the presence
of deposits along the basement membrane (subepithelial,
subendothelial or intramembranous), fusion of the foot
processes of epithelial cells and epithelial cell microvillation.
Clinical observations. All patients were followed by
routine clinical and laboratory techniques. Positive and
negative physical findings were recorded. Serial urinalyses
and serial measurements of blood urea nitrogen and serum
creatinine were performed in all patients. Standard methods
were used to measure serum total proteins, cholesterol and
urea nitrogen. Creatinine clearance was used routinely as
an index of glomerular filtration rate [12], except early in
the study when urea clearances occasionally were used.
Urinary proteins were measured by a modified biuret
method [13] or by the method of Bowman [14]. Serum
protein electrophoresis was performed either with a Beck-
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man Model R-l0l cellulose acetate microzone electro-
phoresis cell or by paper electrophoresis with a Spinco
electrophoresis apparatus [15]. The diagnosis of nephrotic
syndrome was made when proteinuria exceeding 4 g daily,
hypoalbuminemia (serum albumin <3 g/100 ml) and edema
were present. The clinical and laboratory data of these
patients are summarized in Tables I and 2.
Bacteriological and immunological studies. Titers of serum
antibodies against hemolytic streptococci were measured in
all patients. Antistreptolysin 0 titers were measured by the
method of Rantz and Randall [16], antistreptokinase by
the method of Christensen [17] and antihyaluronidase by
the method of Harris and Harris [18]. Variations in anti-
body titers less than two tubes were not considered signifi-
cant. Whole hemolytic complement and 1C globulin were
determined by modification of the methods of Cabot and
Mayer [19] and Mancini, Carbonara and Heremans [20].
The blood remaining in the biopsy needle was cultured in
each instance in thioglycollate medium. All such cultures
were sterile.
Results
Clinicalfeatures and natural history. The clinical features
and natural history of the disease in the 32 patients under
study are summarized in Tables 1 and 2. Proteinuria with
or without the nephrotic syndrome was the initial mani-
festation of renal disease in all patients. Proteinuria alone
was the first sign of the disease in 11 patients; 9 of the
11 developed the nephrotic syndrome weeks or months
later. No evidence of a relationship between the develop-
ment or progression of the disease to streptococcal infec-
tions was obtained in any of the patients by serial measure-
ment of streptococcal serum antibodies. Serum comple-
ment, also measured in all patients, was reduced slightly in
only one. The disease was insidious in onset in all patients.
The clinical courses of the 32 patients in the study are
presented diagramatically in Fig. 1. This figure emphasizes
the early development of uremia and early mortality of
some patients with this disease. Consequently, we have
classified the patients into four groups according to the
rapidity of progression of renal disease.
Twelve patients in the study followed a relatively rapid
course to uremia or death within five years or less of the
clinical onset of their disease (Table 1). Ten of these pa-
tients developed uremia or died within three years of the
clinical onset. Five years was chosen as the dividing point
for analysis because this time interval distinguished patients
following this so-called rapid clinical course to renal failure
from a second group of four patients who became uremic
or died six, eight and nine years after onset. A third group
of nine patients, who have exhibited slow clinical progres-
sion of their renal disease, is still being followed. A fourth
group of seven patients has gone into clinical remission
(Table 2).
1) Rapidly progressive course: Twelve patients are in this
group. Ten developed uremia and all but two are now dead.
Uremia developed within three years in eight of the ten pa-
tients. The remaining two patients (PET, ROB) developed
azotemia at onset and four years and had become uremic
three and five years after the onset. The average period of
time between diagnosis and the appearance of uremia in
this group was 2.7 years. Two nonuremic patients died, one
of sepsis secondary to hemodialysis and the other of a
myocardial infarction.
The presenting manifestation in the ten patients who
became uremic was proteinuria in two and the nephrotic
syndrome in eight. Proteinuria was usually heavy and
persistent. Elevated blood pressure, decreased creatinine
clearance and/or azotemia were present at the clinical onset
in five of the patients who followed the rapid clinical
course.
2) Uremia or death within ten years: This group of four
patients is similar to the rapidly progressive group except
that uremia first appeared at a mean time of 7.4 years after
the onset. This rate of progression is about one-third that
noted in the rapid clinical course group. A fourth patient
died of myocardial infarction at six years without uremia.
The presenting manifestation was proteinuria in the
three patients who became uremic. All showed either hyper-
tension or abnormalities in function at the onset. Except
for the different rate of progression they were indistin-
guishable at the outset from the uremic group shown in
Table 1.
3) Slow progression: Nine patients have exhibited per-
sistent proteinuria for S to 23 years (Table 1). Seven of the
nine have exhibited slow progression of their renal disease
as manifested by hypertension or decreasing creatinine
clearance. Two (CR0 and DRE) have been followed for
periods of 16 and 23 years, respectively, with uremia
developing in one (CR0) 19 years after the onset and
depressed function in the other (DRE) 15 years after the
onset. The remainder have been followed five to nine years
and have developed neither uremia nor signs of remission.
All have exhibited continuous heavy proteinuria except for
one (BOR— Case 12) whose proteinuria decreased mark-
edly to trace amounts 38 months after the onset. This
partial remission lasted several months. Proteinuria has
recurred, but renal functional impairment has not pro-
gressed further. Creatinine clearance is now 35 ml/min.
Five of the seven patients had depressed renal function
at the time they were last studied. Hypertension was present
in three and azotemia in four. All but two of the nine
patients in this category were first diagnosed because of the
presence of the edema associated with the nephrotic syn-
drome.
4) Remission: For purposes of this study, remission was
defined as the disappearance of proteinuria or reduction to
trace amounts. Clinical signs of remission were observed in
seven patients (Table 2). In five, the proteinuria disappeared
and in two there was a marked reduction in the degree of
proteinuria to trace amounts. The interval from the onset
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Table 2. Membranous glomerulonephritis — remissions
Patient Sex Age
at
onset
First
sign
At onset Nephrotic
syndrome
Followup
(yrs)
Remission
BP Funct.a Prot.'
Time
to
remis-
Steroid
therapyBP Funct.a Prot.b
Beganc Dura-
tion
sion
JOH,D M 11 Prot. N N to 18 1 wk 1 wk 1 N N 0 1 wk yes
SHE M 55 N.S. 170/110 UC 87 4+ onset 0.25 2 N BUN 16 0 3 mos yes
REE M 14 N.S. N N 4+ onset 1 yr 7 N N 0 1 yr yes
SAN F 18 Prot. N N 3+ 1 mo 3 mos 6 N N 0 15 mos yes
MEE M 26 Prot. N N to 9 2 mos 2 yrs 5 N N 0 2 yrs yes
SMI M 39 Prot. N UC 54 to 5 none 6 N CC 78 trace 1 yr yes
RIV M 37 N.S. N CC 88 4 onset 1.5 yrs 5 N CC 89 1+ 1.5 yrs yes
Abbreviations: M=Male; F=Female; N=Normal; N.S.=Nephrotic Syndrome; BP= Blood pressure, mm Hg: numerical value
given if it was > 140/90; CC = Creatinine clearance, mI/mm; UC = Urea clearance, percent normal.
a Function (Funct.) result recorded if the creatinine clearance (CC) was <100 mI/mm or urea clearance (UC) <85 percent of normal.
b Proteinuria (Prot.), if number is recorded without + "At onset" it represents maximum g/24 hr, rounded off to nearest whole
number. The word "to" preceding the number means that proteinuria originally was less than 2 g/24 hr. Under "Remission" prot.
represents the last available 24-hour protein measurement. If such a measurement was not available within 3 months or more of
last observation, then protein concentration is recorded.
C Time of onset of nephrotic syndrome after proteinuria was first detected.
Fig. 1. Diagram of the course of the renal
disease in 32 patients with membranous gb-
merulonephritis.
Table 3. Light microscopic changes in membranous glomerulonephritis
Patient Biopsy Time No. of No. Basement Red Vascular Inter- Comment
date between
onset and
biopsy
glomeruli hyalinized membrane
in thickening
specimen
linea diseaseb stitial
fibrosis
1—4 +
BAT 1/25/62 3.5 yrs 30 2 3+ + + 3+ Fig. 7
BAT 12/13/68 7yrs 8 — — 0 fibrinoid
necrosis
— Biopsyof transplant; nodeposits
BOR 2/17/64 3 mos 6 0 1+ 0 0 1+ Fig. 16, 17
BOR 2/ 6/68 41 mos 20 0 2+ + 0 1+ Fig. 3, 18, 19
BRO 11/24/64 lImos 13 0 3+ + 0 0 —
BUK 3/15/63 11 mos 3 0 2+ 0 + 0 —
BUK 6/20/63 l4mos 12 1 2+ + + 2+ —
BUK 11/ 3/65 43 mos 52 25 1+ 0 + 2+ —
COY 9/26/67 2 yrs 4 1 4+ 0 + 3+ —
CR0 11/29/62 l6yrs 9 0 3+ + 0 1+ —
U.S
—I.—..
II!IIN IN INIiNN II
— liVe
!!III!I•!!!III!III
— Uremic or dead
P*. Dead no uremia
— S — S — S —S— S  —S —
IIJIIIIIIIIIIFII I
IfflIIIPIIIIIIUININIINI1IIIIWIWIMIIIIIIIIIIffiIIOIIIIIIIININN
ILIIIIlIIIIINIIIIIIImNIIlIWINIIIIIIJIIlISNUIIIIIIIIIIIIIINSIIIIIIISIIIIN*S
j 2 3 4 5 6 7 8 9 10 II 12 13 14 15 16 22 23
Years
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Table 3 (continued)
of clinical disease to the subsidence of proteinuria varied
from one week to 2.0 years, but in most instances protein-
uria subsided slowly. Only one patient had a significant
decrease in proteinuria within three months after the clinical
onset. The remissions have persisted for one to six years.
This group, at the onset, was indistinguishable from any of
the other groups in Table 1. Four patients presented with
proteinuria and three with the edema of the nephrotic
syndrome. Five had no functional abnormalities while two
showed either depression in function or hypertension.
Patient Biopsy Time No. of No. Basement Red Vascular Inter- Comment
date between
onset and
biopsy
glomeruli hyalinized membrane
in thickening
specimen
line a diseaseb stitial
fibrosis
1—4+
CR0 9/28/65 19 yrs 8 0 4+ 0 + 3+ —
DRE 3/6/67 l4yrs 7 1 3+ + + 1+ —
FIN 4/ 9/69 4 yrs 20 7 4+ + + 3+ Fig. 4, 10
FIN 12/29/69 5 yrs >200 90% 4+ + + 4+ Nephrectomy; numerous
crescents; Fig. 5
FIN 12/27/70 6 yrs >200 0 0 0 0 — Biopsy of transplant; no deposits
FL0 1/17/57 2 wks 21 1 — 0 0 Fig. 2, 12, iSA
FLO 8/15/57 8 mos 3 0 0 0 —
FLO 7/16/58 20 mos 2 0 2+ + + 3+ Fig. l5B
FLO 2/ 7/60 3 yrs >100 10% 4+ + + 4+ Autopsy; Fig. 13, 14, 15C
FRI 6/ 5/64 8 yrs 9 5 4+ 0 + 2+ —
GOR 12/24/58 9mos 8 1 1+ + + 3+ —
HUD 7/ 3/62 1 mo 32 0 1+ + 0 0 —
HUD 6/13/63 1 yr 11 1 1+ + 0 1+ —
JAC 10/26/65 3 yrs 11 2 3+ 0 0 0 —
JOH 11/13/62 i5mos 12 0 0 0 0 0 —
KAS 10/ 3/56 29mos 34 1 3+ + 0 1+ —
KAS 12/ 4/56 31 mos 15 3 3+ + 0 1+ —
KAS 4/22/57 35 mos 18 7 4+ + + 3+ —
KAS 12/19/57 43 mos 4 2 3+ + 0 2+
KIR 7/14/59 3 mos 7 0 0 + + 0 Fig. 6
KIR 1/13/64 57mos 750 -.10% 4+ 0 + 4+ Autopsy
MEE 2/20/56 8 mos 5 0 2+ + 0 0 Fig. 8
MER 4/28/66 4 mos 12 3 1+ 0 + 2+ —
MIL 3/13/64 8mos 11 3 0 Fig.9
MIL 7/ 7/64 11 mos 11 1 1 + + + 1 + —
PET 6/ 8/65 4 mos 10 0 3+ + + I + —
POL 6/24/60 3 yrs 24 5 3 + 0 + 3 + —
RAT 5/25/65 4 mos 12 0 1 + 0 + 1 + —
REE 6/29/60 lOmos 2 0 1+ 0 0 0 —
RIV 3/ 4/66 20 mos 19 0 1 + + 0 1 + —
RIV 12/ 5/67 41 mos 7 1 2+ + 0 2+ —
ROB 11/ 6/64 5 mos 10 0 1+ 0 0 1+ —
ROB 10/21/65 16 mos 17 2 3+ 0 0 2+ —
ROD 5/15/68 '-'48 mos 14 1 2+ 0 + 2+ Fig. 11
RUT 6/13/68 l2yrs 14 9 4+ 0 0 3+ —
SAN 6/ 3/65 5 mos 10 0 0 0 —
SAN 1/19/67 18 mos 15 2 1+ 0 0 0 —
SHE 12/20/60 2mos 12 7 1+ + + 2+ —
SHE 1/ 5/61 3 mos 7 1 1+ + + 2+ —
SMI 2/17/60 8mos 6 0 1+ 0 + 0 —
WAG 4/28/61 2 mos 9 0 2+ + 0 0 —
WAG 1/25/63 23mos 7 0 2+ 1+ —
WAG 3/27/67 74 mos 1 1 — + — 3 + Lipid lakes
WAG 6/24/67 77 mos >100 '-5% 3+ 0 + — Transplant; no deposits
WIL 7/17/67 1 yr 7 0 2+ 0 + 2+ —
WIL 1/26/71 5 >100 0 0 0 0 — Transplant; no deposits
a Red line refers to subepithelial or intramembranous red stain with azocarmine in Heidenhain's connective tissue stain.
b Vascular disease is identified as being absent (0) or present (+). Both arteriolar sclerosis or arteriosclerosis are included under
this heading.
e Interstitial fibrosis is graded on a 1—4+ scale. One small focus = 1+, two to four small foci = 2+, including much of biopsy = 3+,
diffuse fibrosis = 4+.
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Relationship of mode of onset to clinical course. The mode
of clinical onset and the clinical features present at the time
that membranous glomerulonephritis was first detected
were of little value in determining the rapidity of progression
of renal disease. Eight of ten patients developing uremia in
less than five years presented with the nephrotic syndrome,
and only two presented with proteinuria, an observation
which suggests that patients with marked proteinuria and
the nephrotic syndrome at the onset have a greater chance
of becoming uremic within five years than patients with
no edema. On the other hand, 11 of 21 patients presenting
with the nephrotic syndrome survived for more than five
years without developing uremia, a fact which indicates
that the degree of proteinuria initially observed is not
related to the rate of progression of the disease. These
observations suggest that the rapid onset of uremia in
some patients is due to differing rates of progression or
development of the glomerular lesions rather than to the
discovery of long-existent, slowly-advancing glomerular
disease.
The presence of hypertension, azotemia or renal func-
tional impairment at the onset also is of no predictive value
in determining how the disease will progress or go into
remission. Eight patients were hypertensive (blood pressure
greater than 140/90 mm Hg) at the clinical onset of their
disease. Five of these became uremic. On the other hand,
nine of the 25 patients who were normotensive at onset
developed uremia. Of five patients who were azotemic
(BUN >20 mg/100 ml) at onset two became uremic, while
42 % of those patients who were not azotemic at onset
eventually developed uremia. Eighteen patients exhibited
signs of decreased renal function (creatinine clearance
<100 ml/min) at onset. Six of these became uremic as did
eight of the 15 patients whose renal function was normal
at onset. Thus hypertension, azotemia and impaired renal
function at the time of clinical onset of renal disease appear
to be of little value in determining ultimate prognosis.
Mortality. Causes of death of patients are listed in
Table 1. Eleven of the 32 patients have died, eight in
uremia. Death in one uremic patient was due to myocardial
infarction. Two others have died with acute myocardial
infarcts and one with sepsis secondary to a hemodialysis
complication.
Three patients with renal failure received renal trans-
plants; all died. One patient (BAT) died as a result of
rejection, but two (WIL and FIN) died of complications of
immunosuppressive therapy.
Therapy. The effects of therapy could not be accurately
evaluated. The principal therapy employed during this
period (1957 to 1970) was steroids, but the dose, type and
duration of therapy varied widely from patient to patient.
However, the courses of patients relative to whether or not
steroids were used can be summarized in broad terms. Ten
of the 32 patients were not treated with steroids; seven of
these patients not given steroids developed uremia within
ten years of the onset. Also, the disease continued, ap-
parently unaltered and unabated, in the six treated in the
slowly-progressive group of nine patients (Table 1). On the
other hand, all patients in the remission group (Table 2)
were treated with steroids. Despite the apparent favorable
response to therapy, this is neither a controlled nor a
prospective study and we may be studying the natural
history of the disease superimposed on steroid therapy.
The only interpretation possible is that various regimens of
steroid therapy do not have an adverse effect on the course
of membranous glomerulonephritis.
Morphology. 1) Light microscopy: Light microscopic
findings in 56 specimens from 32 patients are summarized
in Table 3. Multiple specimens were obtained from 16 pa-
tients. Tissue obtained included 50 biopsy specimens, two
autopsy specimens and four transplant specimens.
The degree of capillary wall thickening observed varied
from 0 to 4+. In each case all unhyalinized glomeruli were
involved to a similar extent in glomeruli of a single biopsy
specimen. Figs. 2 to 5 illustrate the range of glomerular
alterations. No objectively detectable thickening of the
capillary walls by light microscopy (Fig. 2) was noted in
four, while the remaining 28 patients showed mild I to 2+
(Fig. 3), moderate 3+ (Fig. 4) or very marked 4+ thicken-
ing associated with significant obliteration of the capillary
lumens (Fig. 5). Thickening generally was less severe in
first biopsies obtained shortly after proteinuria was first
detected and was more severe when the first biopsy was
obtained several years after the onset (Table 4). Also,
Table 4. Capillary wall thickness in relation to estimated
clinical duration of disease prior to first biopsy
Years after clinical onset
Otol lto3 4to19
Average degree of thickening 1.3 a 0.2 2.3 0.5 3.3 0.3
No. of patients 18 8 6
a Mean 5EM.
thickening appeared to increase with time in patients ex-
hibiting either the clinically-rapid course or the slowly-
progressive course (see case reports I and 2). However,
exceptions to this general observation suggest that the rate
of change in basement membrane thickening varies from
patient to patient and that the timing of the clinical onset
of the disease is imprecise.
Glomeruli of 19 of the 32 patients showed a thin red line
on Mallory-Heidenhain connective tissue stain in a sub-
epithelial (Fig. 6) or intramembranous position (Fig. 7).
This finding, when present, was useful in diagnosis. Silver
methanamine stains spikes of basement membrane when
thickening is prominent (Fig. 8). Histologically mild cases
of thickening show no spikes. For example, spikes were
present in the patient in Fig. 7 but not the patient in Fig. 6.
Other alterations noted on light microscopy included
occasional lipid lakes [21], prominent hyaline droplet
Fig. 2 Fig. 3
Fig.4 Fig.5
Fig. 2. Patient FLO. First biopsy, January, 1957. Case 1. This glomerulus has no thickening of the capillary walls. See Fig. 12 for
demonstration of deposits by electron microscopy. Mild hyaline droplet change is well illustrated in the cytoplasm of the tubule cells
in the upper left. Hematoxylin and eosin. x 800.
Fig. 3. Patient BOR. Second biopsy. February 6, 1968. Case 2. This glomerulus has mild (2+) thickening of the capillary wall of pe-
ripheral capillary loops. See Fig. 17 1 or electron microscopy. The cytoplasm of tubular cells at the bottom of the photograph is vacuolated,
presumably because of fatty change. H and E. x 800.
Fig. 4. Patient FIN. First biopsy. April 1969. This glomerulus has moderate to marked 3 + thickening of the capillary loops. See
Fig. 10 for electron microscopic appearances of the deposits in this biopsy. H and E stain. x 800.
Fig. 5. Patient FIN. Nephrectomy specimen. December 29, 1969. This glomerulus has very marked thickening of the walls of the
peripheral capillary loops as well as significant obliteration of the capillary lumens. H and E stain. x800.
SE
e
PYS'Pt
Fig. 6 Fig. 7
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Fig. 6. Patient KIR. First biopsy. July 15, 1959. This glomerulus illustrates very slight thickening of the walls of most peripheral
capillary loops. The thin red subepithelial deposit, black in the photograph, is best seen at the arrows. Heidenhain's connective tissue
stain. x 800.
Fig. 7. Patient BAT. First biopsy. January 25, 1962. This portion of a thickened glomerular capillary illustrates intramembranous
deposits which stain red (black in the photograph) amidst the blue (gray in the photograph) staining basement membrane. Heidenhain's
connective tissue stain. x 1650.
Fig. 8. MEE. Biopsy of December 20, 1956. The arrows illustrate tiny spikes of basement membrane stained with the periodic acid
Schiff silver methanamine stain in a patient with 2+ thickening of the capillary wall. x t260.
change (Fig. 2) and fatty or hydropic change (Fig. 4) in the
proximal tubular epithelium. These changes were observed
most commonly in patients in whom proteinuria was
marked at the time of biopsy. Hyaline droplets were also
noted in the cytoplasm of glomerular epithelial cells of
seven of the 32 patients, but the appearance of these
droplets was not related to the age or sex of the patient,
blood pressure, degree of proteinuria or severity of the
amount of subepithelial deposits. Some patients exhibited
arteriolar disease. The kidneys of patients with terminal
renal failure had arteriosclerosis of arcuate and/or inter-
lobular arteries. Interstitial fibrosis and tubular atrophy
were prominent features of granular contracted kidneys
(see FLO, case 1, Fig. 14).
The histopathology of the initial renal biopsy specimen
was an unreliable guide in predicting the rapidity of pro-
gression of membranous glomerular change, even though
the degree of basement membrane thickening and the
amount of glomerular hyalinization correlated well with
whether or not uremia was present at the time of biopsy.
Of 17 patients with mild or moderate (less than 2+) base-
ment membrane thickening at the time of initial biopsy,
five (MER, RAT, ROB, WIL and GOR) developed uremia;
four did so in five years or less after onset. In two patients
(KIR and FLO), thickening of glomerular capillary walls
was not detectable by light microscopy in early biopsies,
yet these patients died in uremia five and three years after
the onset of renal disease. The diagnosis of membranous gb-
merular change in these cases was made by electron micro-
scopy which showed subepithelial electron dense deposits
in electron micrographs and through the appearance of
typical capillary wall thickening in subsequent renal
biopsies.
Multiple tissue specimens were obtained for light micro-
scopic examination in 16 cases. In three instances (SAN,
RIV and SHE) the biopsies were obtained from patients
who went into remission. In no instance was diminution of
capillary wall thickening by light microscopy noted in
folbowup biopsies, but the morphology of the deposits
changed by electron microscopy. Also, no red deposit on
Mallory azan stain was observed in any patient in remission
at the time of biopsy.
Hypertension was often associated with narrowing of
glomerular capillary lumina (3 + capillary wall thickening)
and with the presence of arteriolar disease. Capillary wall
narrowing rarely was present in normotensive patients.
Also, azotemia was associated almost invariably with total
or partial hyalinization of one third or more of the gb-
meruli present in a given biopsy specimen or significant
degrees of capillary wall narrowing (Fig. 5). Interstitial
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Table 5. Electron microscopic findingsa
Name Date Biopsy (B)
Nephrectomy (N)
Transplant (T)
Autopsy (A)
Time between
clinical onset
and biopsy
in months
Location of depositsb Density of deposits
Dense (D)
Lucent (L)
Foot processes'
.Contact Fusion
present + 0—4+
absent 0
E P1 I
BOR 12/17/64 B 3 + — — D (rare L) + 3+
BOR 2/ 6/68 B 41 — — + L (rare D) 0 0
BUK 6/20/63 B 11 — + — D + 3+
BUK 11/ 3/65 B 43 — — + L 0 0
FIN 4/ 9/69 B 48 — + — D + 3+
FIN 12/29/70 AT 60 — — — — — 2+
FLO 1/17/57 B 0.5 + — — D + 4+
FLO 8/1/58 B 20 — + — D + 4+
FLO 2/ 7/60 A 36 — + + D + —
MIL 4/10/64 B 8 + — — D + 3+
MIL 7/ 7/64 B 11 + — — D + 2+
RIV 3/ 4/66 B 20 — — + D & L + 3 +
RIV 12/ 5/67 B 41 — — + L (rare D) — 0
SAN 1/20/66 B 5 + — — D + 1+
SAN 1/19/67 B 19 — — + L — 0
WIL 7/17/67 B 12 — + — D&L + 4+
WIL 3/26/71 AT 21 — — — — — —
CR0 11/30/62 B 192 — + — D & L 0 3+
DRE 3/ 6/67 B 168 — + + D & L 0 & + 2+
HUD 6/13/63 B 12 — + — L 0
KIR 9/ 3/59 B 3 + — — D + 3+
MER 4/28/66 B 4 + — — D + 4+
PET 6/ 8/65 B 4 + — — D + 4+
RAT 5/25/65 B 4 + — — D + 2+
ROD 5/15/68 B 48 — — + D & L + 3+
a No unhyalinized glomeruli were present in biopsy material examined on an additional eight patients.
b E = extramembranous; P1 = partially intramembranous, I = intramembranous.
C Two aspects of epithelial cell morphology are noted. First, is there direct contact of the deposit with the plasma membrane of the
epithelial cell or is the deposit separated from the epithelial cell cytoplasm by a layer of basement membrane-like material? Second,
is there foot process fusion? 0 = no fusion, I + = 1 to 25%, 2+ = 26 to 50%, 3+ = 51 to 75%, and 4+ = 76 to 100% fusion.
fibrosis also was present in most patients with significant
azotemia.
2) Electron microscopy: Twenty-five specimens from
16 patients were examined by electron microscopy (Table 5).
All but three of the specimens examined were from biopsy
material. The remaining three were processed from tissue
fixed in formalin at the time of autopsy. Peripheral capillary
loops were widely patent. Endothelial cell abnormalities
were rare. Occasionally, swollen endothelial cells or cyto-
plasmic ramifications in endothelial cells were noted. Pro-
liferation was not noted. The principal changes were in the
wall of the capillary which was thickened in all glomeruli
examined. The thickening always was due to the presence
of deposits lying external to the endothelium and inner
portion of the lamina densa. Subendothelial deposits were
not seen.
The degree of thickening varied from minimal (Fig. 9) to
very marked (Fig. 10). Deposits, when primarily sub-
epithelial, usually were dense and finely granular (Fig. 9,
10—Case 2). Often, a layer of increased density in the
cytoplasm of the epithelial cells covered the deposits. Also,
the foot processes of the epithelial cells lying over the
deposits often were fused. Deposits were not always dense
nor always clearly subepithelial. Sometimes, they were
separated by broad spikes of basement material with the
same electron density as basement membrane (Fig. 10) and,
occasionally, were covered by basement membrane-like
material (Fig. 11). When incorporated within the basement
membrane, they usually had a vacuolated lucent appear-
ance. A thin layer of material believed to be lamina densa
usually separated deposits from the endothelium (Figs. 9 to
11). No typical tubular arrays of virus-like particles were
seen in deposits or in the cytoplasm of endothelial cells [22].
The deposits were identified according to their location
as extramembranous, partially intramembranous and intra-
membranous. Extramembranous deposits lay mostly out-
side of the basement membrane and where two deposits
were adjacent to one another relatively little basement
membrane-like material separated one from another
(Fig. 9). Partially intramembranous deposits were partially
surrounded by basement membrane-like material (Fig. 10).
However, the epithelial margins of the deposits were not
covered by basement membrane-like material, and no
basement membrane was interposed between the deposit
Fig. 9
Fig. 10
C
C
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and the epithelial cell foot process. Finally, intramem-
branous deposits lay completely encased within basement
membrane (Fig. 11). The electron density and the location
of the deposits seems to correlate with the duration of
clinical symptoms. In those patients whose symptoms were
present for less than one year when the biopsy was ob-
tained, the deposits generally were electron dense and
almost always were extramembranous. Those patients
whose symptoms were present for one to two years had
dense or lucent deposits, singly or in combination. The
location of these deposits was partially intramembranous in
most patients. Finally, in those patients whose symptoms
were present for more than two years before biopsy,
deposits varied in density but all deposits were located in a
partially or wholly intramembranous position.
Whether or not a relationship exists between the character
of the deposit and the course of the disease is not known.
However, electron lucent deposits were absent or minimal
in glomerular basement membranes of patients who
followed a rapid clinical course. Patients with electron
lucent and intramembranous or partially intramembranous
deposits usually underwent remission or followed slow
progression. The converse also appeared to be true; if elec-
tron dense deposits were present for more than two years
after the clinical onset and were not surrounded completely
by basement membrane-like material, the patients generally
followed a rapidly progressive course.
Epithelial cell abnormalities were observed frequently.
Epithelial cell foot processes in contact with deposits
generally were fused (Figs. 9, 10 and 17). Those foot pro-
cesses that were separated from deposits by basement
membrane-like material and which did not appear to lie in
direct contact with deposits usually were not fused. Micro-
villation also was common.
Illustrative Patients
Case report 41:1: Rapidly progressive course (FLO).
A 36 year-old black female [23] developed massive anasarca
without preceding infection or other symptoms. Urinalyses
were free of protein on five occasions in the preceding
ten years, the last being three months prior to the appear-
ance of edema. On admission, the blood pressure was
138/78 mm Hg, and except for anasarca, no other abnormal
physical findings were noted. Protein excretion during the
period following hospitalization ranged from 3 to 20 g/
24 hr. Serum total proteins measured 1.8 g/l00 ml with
0.5 g albumin. Serum cholesterol was 550 mg/l0O ml. The
ASO titer was less than 50 units, and Type 12 antibodies
were not present. BUN and urea clearance were normal.
A renal biopsy specimen obtained 13 days after the onset
of edema showed intact cortical architecture. Twenty-one
glomeruli were present, two of which were hyalinized. The
remainder had no abnormalities by light microscopy
(Fig. 1). No glomeruli were present in the tissue embedded
for electron microscopy; but paraffin-embedded material
was deparaffinized, postosmicated and processed for elec-
tron microscopy 13 years after the biopsy was obtained.
By electron microscopy, small electron dense, extramem-
branous deposits were observed along the epithelial aspects
of the glomerular capillary basement membranes (Fig. 12).
Six months of therapy with large doses of Meticortin ®
and ACTH had no effect on the level of proteinuria or the
patient's nephrotic syndrome. The patient's edema re-
sponded to vigorous diuretic therapy with chlorothiazide,
but heavy proteinuria persisted. A repeat renal biopsy
specimen obtained seven months after the onset revealed
changes similar to those seen on the first specimen. Her
condition remained unchanged until 17 months after the
onset of edema when anemia (Hb 8.2 g/100 ml) and
azotemia (BUN 57 mg/lOO ml) were noted. Serum comple-
ment was normal. A third renal biopsy was performed two
months later. This biopsy showed moderately severe
thickening of the walls of the glomerular capillaries
(Fig. 15b). Also, the cortical architecture now was dis-
rupted by marked diffuse interstitial fibrosis. The patient's
azotemia, anemia and nephrotic syndrome continued.
Finally, 36 months after the onset of edema and after
several dialyses, the patient expired in uremia. Autopsy
examination showed marked bilateral hydrothorax and
hydroperitoneum. The kidneys were small and together
weighed 140 g. Most of the cortex was fibrotic; the proxi-
mal tubules were atrophic and all of the glomeruli were
diseased (Figs. 13 and 14). The capillary walls were enor-
mously thickened. Electron microscopic examination
showed electron dense deposits in intramembranous and
Fig. 9. MIL. First biopsy. March 13, 1964. Extramembranous small dense subepithelial deposits are present. The deposits are covered
by a plasma membrane. The foot processes of the epithelial cells (Ep) are reduced in number. The lumen of the capillary is indicated
by C. There are no abnormalities in the thin endothelial layer. x 11,000.
Fig. 10. FIN. First biopsy. April 9, 1969. Note extreme degree of thickening of the capillary wall. The lumen is at C. The endothelial
layer is not fenestrated. A layer, presumably lamina densa is present at the arrow. External to the inner layer of basement membrane
are dense deposits (D) which are generally covered by plasma membrane and often separated from each other by spikes of material
with the same density as basement membrane. The epithelial cell foot processes are fused. Some villation is present at the lower right.
x 6,600.
Fig. 11. ROD. Biopsy of May 15, 1968. The biopsy was obtained about 48 months after the onset and shows a thickened capillary wall
with lucent deposits (D) incorporated within the basement membrane. The basement membrane is present between the arrows and is
obviously irregularly thickened. A layer, presumably the lamina densa rests on the endothelium (E). The capillary lumen is at C. The
epithelial cell foot processes (Ep) show mild fusion. Lead acetate stain. x 22,900.
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Fig. 14. FLO. Autopsy kidney. February 7, 1960. Representative view of cortex showing numerous diseased glomeruli. All exhibit
similar degrees of capillary wall thickening. There is marked interstitial fibrosis. Present in the fibrous tissue are tubules lined by
atrophic epithelium. x 540.
Fig. 15. FLO. First (A) and third (B) biopsies and autopsy kidney (C). View of representative lobules of glomeruli to show the
progressive increase in capillary wall thickening which occurred in this patient as a function of time. A is two weeks after clinical
onset, B is 20 months after onset and C is 37 months after the onset. Hematoxylin and eosin. x 775.
partially intramembranous locations in the glomerular
capillary walls.
The sequence of changes in glomerular capillary wall
thickness is illustrated in Fig. 15 which shows a lobule from
a glomerulus at the onset, 19 months later and from the
autopsy 36 months after onset. This patient is representative
of the group of patients whose glomerular disease pro-
gressed rapidly from a very mild form undetectable by light
microscopy to a very severe membranous thickening as-
sociated with destruction of the kidney and uremia. Using
proteinuria as a sign of glomerular disease, the onset of
disease is documented quite clearly in this case. It began
sometime in the three months which preceded the develop-
ment of the edema which led to the diagnosis of the disease.
The glomerular disease and proteinuria did not respond to
steroid or ACTH therapy.
Case report 2: Slow progression (BOR). A 43-year old
Caucasian male suffered unremitting swelling of his left
leg after bruising it in a fall. Five weeks later the right leg
began to swell and the nephrotic syndrome was diagnosed.
Fig. 12. FLO. First biopsy. January 1957. Case 1. This micrograph was made from deparaffinized postosmicated Helly's fixed biopsy
material which was embedded in epon and cut by standard techniques. A single capillary (C), the wall of which is well preserved, is
present. Note the small dense deposits at the arrows and elsewhere on the surface of the capillary. Most of the foot processes of the
epithelial cells are fused. x 21,600.
Fig. 13. FLO. Autopsy kidney. February 7, 1960. Several capillaries (C) are present. The walls are enormously thickened due to a large
amount of dense deposit material, most which appears to be intramembranous and subepithelial in location. This kidney tissue had
been stored in formalin for five years prior to postosmication and preparation for electron microscopy. x 2719.
Fig. 14
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Blood pressure was 125/80 mm Hg, serum cholesterol level
was 536 g/100 ml, creatinine clearance 73 mI/mm and
protein excretion was 2.5 to 4.6 g/24 hr. While in the
hospital, he developed symptoms of pulmonary embolism,
but at operation, had no thrombi in the vena cava or renal
veins. Renal biopsy specimens obtained from the lower
poles of both kidneys showed similar changes of diffuse
glomerular capillary wall thickening with no proliferative
or exudative changes (Fig. 16). Electron microscopic exami-
nation of the glomeruli revealed electron dense deposits
along the epithelial aspect of the glomerular capillary
basement membrane. The deposits were dense and oc-
cupied a predominantly extramembranous location (Fig. 17).
Prednisone therapy was administered intermittently for
38 months. Proteinuria gradually decreased from a high of
12 g/24 hr during the year after onset to a low of 0.9 g/
24 hr 41 months after onset. A second renal biopsy speci-
men, 38 months after the first, showed glomerular capillary
walls which appeared to be slightly thicker than those ob-
served at the time of the first biopsy (Fig. 18). Mild focal
interstitial fibrosis was present. Deposits with coarsely
granular components were now present in an intramem-
branous position (Fig. 19).
Following the biopsy, the patient's condition remained
relatively stable; he was not edematous at our last examina-
tion six years after the onset of the nephrotic syndrome.
Blood pressure was 130/80mm Hg; 24-hr urine protein,
3.1 g; BUN 21 mg/100 ml; serum creatinine, 1.2 mg/100 ml;
creatinine clearance, 36 mI/mm; and serum cholesterol,
321 mg/l00 ml. This patient is representative of the group
of patients whose renal disease has progressed slowly.
Renal function was depressed slightly at the onset, and
after six years is one third of normal and about one half
of the initial value. The degree of basement membrane
thickening by light microscopy has increased and significant
interstitial fibrosis was present in the second biopsy. The
subepithelial deposits on the first biopsy were electron
dense but were incorporated within the basement membrane
and were electron lucent three years after the onset. The
difference in the rate of progression and quality of pro-
gression of the glomerular lesions in this case as compared
to Case 1 is quite striking. It is not clear whether steroid
therapy had any effect. The proteinuria decreased to as low
as 0.9 g/24 hr several months after therapy was stopped and
a temporary remission of several months duration may have
occurred.
Case report fl 3: Remission (SAN). A previously healthy
18 year old Caucasian female entered the hospital in the
23rd week of her first pregnancy. Her pregnancy was
uneventful until the 19th week when proteinuria was
detected on routine urinalysis. It ranged from 12 to 14 g/day
and was associated with a weight gain of 15 lb. Serum
albumin was 1.1 g/l00 ml and the blood pressure was
normal. Treatment with diuretics and prednisone (80 mg/
day) was begun in the 23rd week.
By the 27th week of the pregnancy, the legs and hips
were markedly edematous. Urinalysis showed 4+ protein-
uria, 0 to 3 red blood cells and 10 to 15 white blood cells
per high power field. BUN was 21 mg/lOO ml, serum
creatinine 1.3 mg/lOO ml and serum uric acid 6.6 mg/lOO ml.
Three L.E. cell preparations were negative as was a serologic
test for syphilis. Serum complement was 46 hemolytic
units/ml (normal: 35 to 50 units), while anti-streptolysin 0
titer was below 50 Todd units/mi. Serum proteins were 3.0
and albumin 0.7 g/100 ml. The serum cholesterol was
705 mg/lOOm!. Urine protein excretion continued to range
from 12 to 18 g/day. The creatinine clearance was 80 mI/mm.
She was placed on a low sodium diet and diuretics, while
the dosage of prednisone was adjusted to 40 mg daily
between the 27th to 31st week. During this period edema
completely regressed and she lost 27 lb, but the heavy
proteinuria was unaltered until the last month of pregnancy.
At that time protein excretion fell to levels of 3 to 5 g/day
while serum albumin increased to 1.6 g/l00 ml. At 41-1/2
weeks gestation the patient went into spontaneous labos
and delivered a healthy 4 pound 8 ounce boy. On the 12th
postpartum day a percutaneous biopsy of the right kidney
was performed. Light microscopy revealed a normal cortical
architecture. All glomeruli were abnormal and showed
diffuse but slight thickening of the walls of the peripheral
capillary loops. A thin red stain was apparent on the
epithelial aspect of the basement membrane on the Mallory
azan stain. Electron microscopy of six glomeruli showed
electron dense subepithelial deposits external to the lamina
densa (Fig. 20) in all peripheral capillary loops. These were
generally dense and only rarely were included in the base-
Fig. 16. BOR. First biopsy. December 17, 1964. Portion of a glomerulus showing mild thickening of the walls of the peripheral capillary
loops. Heidenhain's connective tissue stain. x 800.
Fig. 17. BOR. First biopsy. December 17, 1964. Portions of walls of two capillaries (C) have dense subepithelial deposits (D). Foot
process fusion of the epithelial cells (Ep) is extensive. Lead acetate stain. x 5,500.
Fig. 18. BOR. Second biopsy. February 6, 1968. This biopsy was obtained 38 months after the first biopsy and is photographed at the
same magnification as Fig. 16, with which it should be compared. Note the walls of the peripheral capillary loops are generally
thicker. Heidenhain's connective tissue stain. x 800.
Fig. 19. BOR. Second biopsy. February 6, 1968. This electron micrograph of a part of a glomerular capillary (C) illustrates that sub-
epithelial deposits (see Fig. 17) no longer are present in this patient. Rather the deposits (D) are variably iucent and present within the
basement membrane. The endothelial cell layer (E) as in this photograph, often was not fenestrated. Epithelial cell foot processes
generally were not fused. Immunofluorescent techniques showed heavy staining with IgG along the basement membrane. Stains for
fl1C were negative as were stains for fibrinogen, IgA and 1gM. Lead acetate stain. x 18,100.
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Fig. 20
Fig. 21
Fig. 20. SAN. First biopsy. July 27, 1965. Portion of a wall of a glomerular capillary showing endothelium (E), prominent deposits (D),
and fused epithelial cell foot process (Ep). The density of the epithelial cell cytoplasm immediately adjacent to the deposits (below
the symbol Ep) is increased slightly. Lead acetate staining. x 12,000.
Fig. 21. SAN. Second biopsy. January 19, 1967. Portion of a glomerular capillary wall on a biopsy obtained 13 months after the first
biopsy. The lumen of the capillary (C) is lined by endothelium (E) which rests on a thickened basement membrane which is irregular
on the epithelial side (arrow) and focally lucent. The foot processes are normal. Immunofluorescent techniques showed IgG along the
basement membrane on both the first and second biopsy. fl1C was negative on the seond biopsy and not tested on the first. x 23,491.
ment membrane. The cytoplasm of the epithelial cells
generally was opaque immediately adjacent to the deposits.
Foot processes were fused over the deposits. Microvillation
also was prominent.
At the time of discharge from the hospital, protein ex-
cretion had fallen to 0.4 g/24 hr and prednisone was re-
duced to 30 mg daily. Seven months postpartum the pred-
nisone dosage was 20 mg per day, and protein excretion
varied from 0.1 to 0.8 g/day with a creatinine clearance of
109 to 138 ml/min. Percutaneous renal biopsy was un-
successful.
Prednisone was discontinued 15 months postpartum,
and when she reentered the hospital 19 months after
delivery her Cushingoidappearancehad disappeared. Protein
excretion was never more than a trace per 24 hr. The serum
albumin was 3.3 g/l00 ml, the serum cholesterol 215 mgI
lOOml and the creatinine clearance l3Oml/min. A per-
cutaneous renal biopsy was performed and showed normal
cortical architecture. Two of 15 glomeruli were hyalinized.
All unhyalinized glomeruli had slight diffuse thickening of
the basement membranes, but no red subepithelial deposits
on connective tissue stain. Electron microscopy (Fig. 21)
showed a thickened lamina densa in five glomeruli. How-
ever, discrete subepithelial deposits no longer were present.
There appeared to be an inner zone of basement membrane
and an outer irregular zone of lesser density in the same site
occupied by deposits on the first biopsy.
Four years after delivery, and while in the first trimester
of her second pregnancy, her blood pressure, renal function
and urinanalysis were normal. The pregnancy was com-
pleted without difficulty in another city with the spontane-
ous delivery of a healthy male. Renal biopsy was not done.
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Discussion
Distinctive changes in glomerular morphology have been
used to define a glomerular disease occurring in a group
of patients with persistent or prolonged periods of protein-
uria. The glomerular lesion is progressive in most cases but
may occasionally undergo remission. The rate of glomerular
destruction is variable, and in the rapidly progressive form
of the disease, renal failure can occur within several years.
The subepithelial and intramembranous deposits that are
found in all patients with active disease often change in
appearance with time; they lose density and become in-
corporated into the basement membrane of some patients,
particularly when the disease has progressed slowly or
undergone remission. No clinical or histologic features of
the disease at the time of the first diagnosis are useful in
predicting the likelihood or rate of progression.
The average age of the patients at onset was 37.3 years,
and three-quarters of the patients were male. Other studies
in which similar strict criteria of diagnosis were employed
have shown a less marked preponderance of males to
females [4, 5, 24, 25]. It is interesting that five of the
ten patients who followed the rapidly-progressive course
were female; males predominated in all other groups.
Whether this difference in sex incidence is significant or
occurred by chance alone is unknown.
The incidence of mortality and remission varies from
one reported series to another, and it is not known whether
the rates vary because of differences in patient populations
or as the result of incomplete follow-up. Half of our pa-
tients died, but death in renal failure only occurred in 13/32
or 41 %. Pollak et al [2] and Gluck et al [24] have observed
a much smaller incidence of renal failure than reported in
this study or in the studies of Forland and Spargo [4] and
Ehrenreich and Churg [5]. Remissions have been reported
in all large series [2, 4, 5, 24, 25].
Gross hematuria was not observed; microscopic hema-
tuna was common but its severity and incidence did not
differentiate between groups of patients. Patients who
developed uremia tended to have marked proteinuria which
persisted. However, the degree of proteinuria on single
urinalyses did not provide a clue as to the eventual
course of the patient.
Nature of the lesions. In this condition the thickening of
the capillary wall is due to the presence of deposits. When
the deposits are principally subepithelial, they usually are
electron opaque and appear dense; they stain with eosin,
azocarmine and osmium and faintly with Schiff reagent,
but they are silver methanamine negative after digestion
with periodic acid. These histochemical staining reactions
are nonspecific and are those characteristic of proteins.
The deposits contain immune gamma globulin (IgG), often
1C globulin [24, 26—29], and on occasion, other immuno-
globulins. These data, taken together, establish that pro-
teinaceous material including immune globulins are present
in the deposits. They do not establish whether globulins are
the principal component of the deposits, but most in-
vestigators assume that this is the case [30].
When the disease is slowly progressive, much new
basement membrane-like material appears around the
deposits, which gradually become incorporated into the
glomerular basement membrane. The new basement mem-
brane-like material first is identified by light microscopy as
silver methanamine positive projections from the capillary
wall (Fig. 8) [7]. When the lesion is fully developed, the
thickened capillary wall appears vacuolated because the
deposits usually lose their affinity for stains [5]. These
vacuoles within the basement membrane probably re-
present altered partially degraded deposits, and by electron
microscopy often consist of granular debris or circular
profiles of unidentifiable nature. The sequential studies
presented in this paper indicate that dense deposits appear
earlier and precede the vacuolated, granular intramem-
branous variety. The observation that inconspicuous but
dense subepithelial deposits are younger than the lesions
associated with thick capillary walls and intramembranous
deposits is supported by clinicopathologic correlations
made in all recent electron microscopic studies [4, 5, 24, 29].
Bariéty et al [29] and Gluck et al [24] have classified
glomerular lesions in membranous glomerulonephritis into
four stages: in stage I or II the deposits are principally
dense and subepithelial, and in stage III or IV the deposits
are intramembranous. Similarly, Ehrenreich and Churg [5]
classify the glomerular lesions as early, advanced and late.
Both assessments imply that the dense deposits occur early,
that the intramembranous deposits occur late, and that
the lesions are progressive. This staging system may be
generally true but some exceptions to it have been revealed
by the natural history approach to the study of this disease.
First, this disease does not progress in all patients. The
corollary of this observation is that patients who enter
remission pass through a stage in which the deposits are
intramembranous. Therefore, a process characteristic of an
advanced stage of this disease develops in patients whose
basement membrane is returning toward normal. Second,
the staging system does riot include the rapidly progressive
form of the disease which is illustrated by Case 1 and by
FIN (Fig. 10). These patients have not passed through
stages III or IV. Rather, the glomerular capillary walls have
become very thick because of abundant dense deposits
which remain in contact with the cytoplasm of the epithelial
cells and become neither vacuolated nor completely in-
corporated within the basement membrane. Thus, the
staging technique currently is incomplete and only has
value in single biopsies on the extremes of the scale; stage I
represents an early lesion which can enter remission and
stage IV is late and probably will not remit spontaneously.
The fact that patients with dense subepithelial deposits
could progress without passing through a significant vacuo-
lated intramembranous phase has not been reported
previously. All the patients in the rapidly-progressive
group on whom we were able to obtain electron microscopy
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exhibited this sequence, and when renal failure had de-
veloped, showed very thick capillary walls with electron
opaque deposits still in contact with the epithelial cell
cytoplasm.
Pat hogenesis of metnbranous glomerulonephritis. The
pathogenesis of most cases of this disease remains un-
established. However, much indirect evidence supports the
idea that the common morphologic feature, i.e., the sub-
epithelial and intramembranous deposits, is the result of
collection of circulating soluble antigen antibody com-
plexes by the glomeruli [31]. Strong support for the idea
that the deposits contain complexes is the fact that similar,
but isolated, subepithelial structures, which contain all three
components of a complex, namely, antigen, antibody and
complement, occur in diseases such as post-streptococcal
glomerulonephritis [32, 33] or serum sickness [31]. Related
evidence is the fact that morphologically similar, but diffuse
subepithelial deposits containing only two components of
a complex, i.e., IgG and 131C, are present in man with
diffuse membranous glomerulonephritis [26—29, 34]. An-
tigen usually has not been identified. Thus, our 32 patients
have "idiopathic" diffuse membranous glomerulonephritis.
It is noteworthy, however, that an identical lesion has been
described in a number of conditions in man in which an
antigen is potentially present. These conditions include
congenital [35—37] and secondary lues [38, 39], filariasis
[40], Quartan malaria [41], Sjogren's syndrome [42, 43],
rheumatoid arthritis [44—47], neoplasia [48, 49], hepatitis
[50], tridione [51] and penicillamine therapy [52] and gold
[53] and mercury [54] intake.
Perhaps the strongest indirect evidence that the disease
in man is related to complexes comes from the observation
that it has been possible to produce morphologically
identical lesions in experimental animals by inducing a con-
dition in which circulating complexes are more or less
continuously present. In one of these models, chronic
serum sickness, the disease should be self-limited if antigen
injection is stopped [31]. In another, autologous antigen
induces the complex and the disease should be and is pro-
gressive [55—59]. It is not known whether either of these
mechanisms are involved in the idiopathic form of the
disease in man, but the hypothesis that remission develops
when conditions become inappropriate for the formation
of complexes is very attractive. Unfortunately it is im-
possible to prove because of numerous unknowns about
soluble complexes in man such as the relationship of the
size of complexes to filtration, the antigen involved, and
the rates of production, clearance, degradation, and other
factors.
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